(MedPage Today) — BARCELONA — Rheumatoid arthritis (RA) patients were exceedingly unlikely to develop refractory disease when their first medical therapy was a tumor necrosis factor (TNF) inhibitor, a researcher reported here.
Among patients…
Source link : https://www.medpagetoday.com/meetingcoverage/eular/116017
Author :
Publish date : 2025-06-11 19:24:00
Copyright for syndicated content belongs to the linked Source.
